Mahvish Muzaffar MD
Hematologic Oncology
Associate Professor Program Director Hematology Oncology Fellowship Brody School of Medicine/East Carolina University
Join to View Full Profile
524 Moye Blvd, Greenville, NC 27834Vidant Cancer Care at the Eddie and Jo Allison Smith Tower in GreenvilleGreenville, NC 27834
Phone+1 252-816-2273
Dr. Muzaffar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ToledoFellowship, Hematology and Medical Oncology, 2011 - 2013- University of ToledoResidency, Internal Medicine, 2008 - 2011
Alma Atinskij Med InstClass of 1998
Certifications & Licensure
NC State Medical License 2013 - 2025
OH State Medical License 2008 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy Start of enrollment: 2014 Feb 24
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
- Breast Cancer WEight Loss Study (BWEL Study) Start of enrollment: 2016 Sep 16
- Join now to see all
Publications & Presentations
PubMed
- Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani
JAMA Surgery. 2025-02-01 - Reply to G.B. Mann et al and S. Sorscher.Reshma Jagsi, Kent A Griffith, Eleanor E Harris, Jean L Wright, Abram Recht
Journal of Clinical Oncology. 2024-06-01 - 2 citationsPlasma cell-free RNA PD-L1 or tissue PD-L1 protein expression and outcomes with first-line immunotherapy in metastatic non-small cell lung cancer.Paul R Walker, Sriraksha Jayananda, Melisa Pasli, Mahvish Muzaffar
The Journal of Liquid Biopsy. 2024-03-01
Press Mentions
- How Coronavirus Changed Our Health BehaviorsNovember 2nd, 2020
Greenville Doctors Give Breast Cancer Screening AdviceOctober 28th, 2016
Outcomes Poorer for Black Patients with Early Breast Ca -Five-year disease-specific survival 94% vs 99% for whitesAugust 9th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
